Gilead Falls as CVS Hasn’t Yet Added PrEP HIV Shot to Drug Plans
Gilead Sciences Inc.’s shares fell after CVS Health Corp said it hasn’t yet added its new HIV prevention shot to…
Tag: Gilead
Gilead Sciences Lifts Annual Outlook As Yeztugo Launch Nears
Gilead Sciences (NASDAQ:GILD) announced its second-quarter 2025 earnings and revised annual outlook after the market closed on Thursday. The HIV…
Stock Movers: LMT, Monster, Gilead (Podcast)
Source: Bloomberg, 4:23 www.bloomberg.com #Stock #Movers #LMT #Monster #Gilead #Podcast
Why Gilead Sciences (GILD) Appeals to Income Investors in the Pharma Sector
Gilead Sciences, Inc. (NASDAQ:GILD) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. Why Gilead Sciences…
FDA approves Gilead HIV prevention injection lenacapavir
The Food and Drug Administration on Wednesday approved Gilead’s twice-yearly antiviral injection for preventing HIV — a milestone that the…
AstraZeneca, Pfizer, Gilead release cancer drug data
Attendees walk through the lobby at the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg…
Gilead Sciences, Inc. (GILD) and Kite to Present Breakthrough Cancer Therapy Data at 2025 ASCO and EHA
Gilead Sciences, Inc. (NASDAQ:GILD) plans to present over 20 research abstracts—spanning both Gilead and its cell therapy unit Kite—at two…